A new study from the University of Iowa finds that many drug prices actually drop after pharmaceutical company mergers, challenging the belief that mergers are the primary cause of rising drug prices in the United States. The study finds the price drops are due to cost savings achieved by merging firms that have overlapping products that treat the same medical condition.
Go to Source
https://medicalxpress.com/rss-feed/